Skip to Main Content

FLORIDA PHARMACY ACT

Florida pharmacy law is found in statute 465- the Florida Pharmacy Act. The practice of pharmacy ensures that every licensed pharmacist must meet a minimum requirement to practice safely, and involves compounding, dispensing, and consulting patients. Despite the practice setting traditionally being hospital or retail pharmacy, the underlying foundation remains the same and is important to understand. A few chapters to skim through on the FL Board of Pharmacy website under the resources tab is chapters 456, 499, 893 and 64B-16.

Laws and Regulations relevant to the profession of Pharmacy

These laws will provide a general outline for your studying and the overall framework for pharmacy practice:

FL LAW RECENT CHANGES

Class III Institutional Pharmacies (as of October 2018)

Created for hospital-affiliated institutional pharmacies, which can also include a central distribution facility (authorized by a Class II permit, see section…).

Class III Institutional permittees can:

  1. Dispense, distribute, compound, and fill prescriptions for medicinal drugs.

  2. Prepare prepackaged drug products.

  3. Conduct other pharmaceutical services for the affiliated hospital and for entities under common control that are each permitted under Chapter 465, F.S., to possess medicinal drugs.

  4. Provide the aforementioned services to an entity under common control that holds an active health care clinic establishment permit as required under Chapter 499, F.S.

Updated CE Requirements (as of June 2018)

Rule 64B16-27.831(6), now provides that all licensed pharmacists need to complete a Board-approved 2-hour continuing education course (CE), on the “Validation and Counseling of Prescriptions for Controlled Substances and Opioids”, during the biennium ending on September 30, 2019 and every biennium thereafter.

The course should cover the following objectives (per Rule 64B16-27.831(6)):

  • (a) Ensuring access to controlled substances for all patients with a valid prescription;

  • (b) Use of the Prescription Drug Monitoring Program’s Database;

  • (c) Assessment of prescriptions for appropriate therapeutic value;

  • (d) Detection of prescriptions not based on a legitimate medical purpose;

  • (e) The laws and rules related to the prescribing and dispensing of controlled substances.

  • (f) Proper patient storage and disposal of controlled substances;

  • (g) Protocols for addressing and resolving problems recognized during the drug utilization review to include but not limited to the following:

    1. Drug/drug interactions;

    2. Side effects;

    3. High dose/low dose guidelines; and

  • (h) Education on the provision of section 381.887, F.S., Emergency treatment for suspected opioid overdoses and on the State Surgeon General’s Statewide Standing Order for Naloxone ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.